Abstract
In this in silico study, it was investigated whether phycobilins (phycocyanobilin, phycoerythrobilin and phycourobilin) could be inhibitors of the activity of the main proteins of the SARS-CoV-2 virus. All chromophores exhibited a binding energy value of ??37 kJ mol-1 for PLpro-WT, PLpro- -C111S, helicase-ANP binding site, Nsp3-macrodomain, Nsp3-MES site and Nsp10/14-N7-Mtase. Phycocyanobilin showed the highest binding energy of ?44.77 kJ mol-1 against the target protein PLpro-C111S. It was found that, apart from the hydrogen bonds and hydrophobic interactions, phycobilins also form electrostatic interactions with the SARS-CoV-2 proteins. The network of non-covalent interactions was found to be important for the stability of the examined virus proteins. All phycobilins have good pharmacokinetic and drug- -likeness properties. This study?s results suggest that the screened phycobilins could serve as promising drugs for the treatment of COVID-19 with further rigorous validation studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
